Results 231 to 240 of about 39,021 (326)

Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis. [PDF]

NPJ Precis Oncol
Fang H, Luo H, Li S, Yan N, Xu S, Liu N, Wang X, Xu T, Cheng W, Liu Y, Yu C, Fang S.   +11 more
europepmc   +1 more source

Updates on Liquid Biopsy and ctDNA in Transplant Oncology [PDF]

Abigail Loszko, Matthew Byrne, Cristina Jiménez-Soto, Koji Tomiyama, Yuki Bekki, Roberto Hernandez‐Alejandro   +5 more
openalex   +1 more source

Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making. [PDF]

Cancers (Basel)
Theocharopoulos C, Machairas N, Ziogas IA, Mungo B, Del Chiaro M, Glatzounis GK, Schulick R, Sotiropoulos GC.   +7 more
europepmc   +1 more source

Profiling of Extracellular Vesicles of Non‐Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance

Journal of Extracellular Vesicles, Volume 15, Issue 1, January 2026.
Non‐invasive biomarkers are needed to further personalize EGFR tyrosine kinase inhibitor (EGFR TKI) osimertinib treatment in non‐small cell lung cancer (NSCLC) patients. By analysing the proteome of extracellular vesicles (EVs) isolated from an osimertinib resistant NSCLC cell line and from serum of patients given osimertinib in second line within the ...
Albano Cáceres‐Verschae, Petra Hååg, Sofia Joelsson, Per Hydbring, Bo Franzén, Ákos Végvári, Inger Johanne Z. Eide, Nupur Agarwal, Siddharth Sourabh Sahu, Fredrik Stridfeldt, Luigi De Petris, Apurba Dev, Simon Ekman, Odd Terje Brustugun, Rolf Lewensohn, Kristina Viktorsson   +15 more
wiley   +1 more source

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors. [PDF]

Nat Commun
Magbanua MJM, Manon NA, Wolf DM, Rivero-Hinojosa S, Ahmed Z, Sayaman RW, Tin A, Renner D, Kalashnikova E, Brown-Swigart L, Hirst GL, Yau C, Li W, Isaacs C, Shatsky RA, Clark AS, Zimmer A, Delson AL, Rodriguez A, Liu MC, Pohlmann PR, Esserman LJ, Rugo HS, DeMichele A, van 't Veer L.   +24 more
europepmc   +1 more source

SY26-4 New epigenetic technologies for ctDNA analysis [PDF]

Takayuki Shibata
openalex   +1 more source

Harnessing early postoperative MRD and VAF dynamics for precision prognosis in resected colorectal liver metastases. [PDF]

J Cancer Res Clin Oncol
Li P, Li T, Huang M, Liu Y, Liu P, Wu Y, Li X, He R, Gan Y, Hong Y, Wang P, Lin J, Huang M.   +12 more
europepmc   +1 more source

Dynamics of ctDNA in patients with NSCLC

, 2019
A.S. Zhabina, A. Mjslik, Fedor Moiseenko, В. Моисеенко, M. Stepanova   +4 more
openalex   +1 more source

ctDNA to Predict Treatment Response in Head and Neck Squamous Cell Carcinoma: A Systematic Review

The Laryngoscope, Volume 136, Issue 1, Page 50-62, January 2026.
This systematic review aims to investigate the role of plasma circulating tumor DNA in head and neck cancer surveillance. We conducted a systematic review to comprehensively assess the findings and quality of existing literature on this topic. Our findings show that ctDNA monitoring post‐treatment likely has utility in HNSCC surveillance.
Oliver Jones, Sumrit Bola, Stuart C. Winter   +2 more
wiley   +1 more source

Individualized management strategies for advanced non-small cell lung cancer with <i>EGFR</i> exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report. [PDF]

Oncol Lett
Zhu X, Sun Y, Cai R, Zhang W, Zhang X, Song A, Chen X, Liu C, Zhou J.   +8 more
europepmc   +1 more source